Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In VivoZiying Wei(Beijing University of Chinese Medicine), Junling Cao(Beijing University of Chinese Medicine)Frontiers in PharmacologyOctober 14, 202110.3389/fphar.2021.750815Cited by 31SaveCiteExport RISWatch citationsRelated PapersNetwork pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer|Medicine|2023|21